Guayama Inspection Delay Unlikely To Impact Launches, Wyeth Says
Executive Summary
FDA's inspection of Wyeth's Guayama, Puerto Rico manufacturing facility is taking longer than anticipated, but the firm does not expect the delay to hold up the launches of compounds it has pending at FDA, Chief Financial Officer Kenneth Martin said during a Feb. 28 conference call